Page 1 of 6

Lymphoma Therapeutic Drugs Review - Hodgkin, Mantle Cell, Follicu...

Continues for 5 more pages »
Read full document

Lymphoma Therapeutic Drugs Review - Hodgkin, Mantle Cell, Follicular, Natural Killer Cell H1 2013

Page 1 of 6
RnR Market Research Offers “Hodgkin, Mantle Cell, Follicular & Natural Killer Cell Lymphoma Therapeutic Review H1 2013” Report at US$ 2000 (Single User License). The report got published in Feb 2013.Global Markets Direct’s, ‘Hodgkin, Mantle Cell, Follicular & Natural Killer Cell Lymphoma – Pipeline Review, H1 2013′, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Hodgkin, Mantle Cell, Follicular & Natural Killer Cell Lymphoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Hodgkin, Mantle Cell, Follicular & Natural Killer Cell Lymphoma. Hodgkin, Mantle Cell, Follicular & Natural Killer Cell Lymphoma – Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.Scope- A snapshot of the global therapeutic scenario for Hodgkin, Mantle Cell, Follicular & Natural Killer Cell Lymphoma. - A review of the Hodgkin, Mantle Cell, Follicular & Natural Killer Cell Lymphoma products under development by companies and universities/research institutes based on information derived from company and industry-specific sources. - Coverage of products based on various stages of development ranging from discovery till registration stages. - A feature on pipeline projects on the basis of monotherapy and combined therapeutics. - Coverage of the Hodgkin, Mantle Cell, Follicular & Natural Killer Cell Lymphoma pipeline on the basis of route of administration and molecule type. - Key discontinued pipeline projects.

- Latest news and deals relating to the products.Get a Report Copy of Natural...